Related references
Note: Only part of the references are listed.Oxidative stress and Parkinson’s disease: mechanisms and perspectives of treatment
E. A. Katunina et al.
Zhurnal Nevrologii I Psikhiatrii imeni S S Korsakova (2016)
Therapeutics targeting the inflammasome after central nervous system injury
Juan Pablo De Rivero Vaccari et al.
TRANSLATIONAL RESEARCH (2016)
Prevention of the degeneration of human dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolism
Liudmila Efremova et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome
Yiqing Yan et al.
CELL (2015)
The Pro-inflammatory Cytokine Interleukin-1 is a Key Regulatory Factor for the Postictal Suppression in Mice
An-Feng Tao et al.
CNS NEUROSCIENCE & THERAPEUTICS (2015)
Resting-State Functional Brain Networks in Parkinson's Disease
Hugo C. Baggio et al.
CNS NEUROSCIENCE & THERAPEUTICS (2015)
Imaging Brain Networks in Neurodegenerative Diseases
Yong He
CNS NEUROSCIENCE & THERAPEUTICS (2015)
Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous α-synuclein fibrils
Atsushi Tsujimura et al.
NEUROBIOLOGY OF DISEASE (2015)
A lipid switch unlocks Parkinson's disease-associated ATP13A2
Tine Holemans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Neuroinflammation in Parkinson's disease and its potential as therapeutic target
Qinqin Wang et al.
TRANSLATIONAL NEURODEGENERATION (2015)
Mechanisms and Potential Therapeutic Applications of Microglial Activation after Brain Injury
Jong-Youl Kim et al.
CNS NEUROSCIENCE & THERAPEUTICS (2015)
Knockdown of interleukin-1 receptor 1 is not neuroprotective in the 6-hydroxydopamine striatal lesion rat model of Parkinson's disease
Sinead Walsh et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2015)
Astrocyte Development and Heterogeneity
Omer Ali Bayraktar et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Cysteine cathepsins and extracellular matrix degradation
Marko Fonovic et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Inhibition of cysteine cathepsin B and L activation in astrocytes contributes to neuroprotection against cerebral ischemia via blocking the tBid-mitochondrial apoptotic signaling pathway
Min Xu et al.
GLIA (2014)
Uncoupling protein 2 deficiency aggravates astrocytic endoplasmic reticulum stress and nod-like receptor protein 3 inflammasome activation
Ming Lu et al.
NEUROBIOLOGY OF AGING (2014)
Neuron-glia networks: integral gear of brain function
Gertrudis Perea et al.
Frontiers in Cellular Neuroscience (2014)
Astrocytic modulation of blood brain barrier: perspectives on parkinson's disease
Ricardo Cabezas et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Inflammasonnes in neuroinflammation and changes in brain function: a focused review
Gaurav Singhal et al.
FRONTIERS IN NEUROSCIENCE (2014)
Parkinson's disease-associated human P5B-ATPase ATP13A2 increases spermidine uptake
Diego P. De La Hera et al.
BIOCHEMICAL JOURNAL (2013)
Antimalarial Drug Artemisinin Extenuates Amyloidogenesis and Neuroinflammation in APPswe/PS1dE9 Transgenic Mice via Inhibition of Nuclear Factor-κB and NLRP3 Inflammasome Activation
Jian-Quan Shi et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathies
Claudia Manzoni et al.
FASEB JOURNAL (2013)
Cathepsin B Contributes to Autophagy-related 7 (Atg7)-induced Nod-like Receptor 3 (NLRP3)-dependent Proinflammatory Response and Aggravates Lipotoxicity in Rat Insulinoma Cell Line
Shali Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
Melanie Bruchard et al.
NATURE MEDICINE (2013)
Analysis of LRRK2 accessory repeat domains: prediction of repeat length, number and sites of Parkinson's disease mutations
Ryan D. Mills et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Astrocytes: more than just glue
Peter Baxter
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2012)
Lysosomal storage disorders: The cellular impact of lysosomal dysfunction
Frances M. Platt et al.
JOURNAL OF CELL BIOLOGY (2012)
Deficiency of ATP13A2 Leads to Lysosomal Dysfunction, α-Synuclein Accumulation, and Neurotoxicity
Marija Usenovic et al.
JOURNAL OF NEUROSCIENCE (2012)
Regulation of Intracellular Manganese Homeostasis by Kufor-Rakeb Syndrome-associated ATP13A2 Protein
Jieqiong Tan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Glia: Initiators and Progressors of Pathology in Parkinson's Disease
Glenda M. Halliday et al.
MOVEMENT DISORDERS (2011)
Pathogenic Lysosomal Depletion in Parkinson's Disease
Benjamin Dehay et al.
JOURNAL OF NEUROSCIENCE (2010)
KATP Channel Openers Protect Mesencephalic Neurons Against MPP+-Induced Cytotoxicity Via Inhibition of ROS Production
Juan Xie et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions
Yaping Chu et al.
NEUROBIOLOGY OF DISEASE (2009)
Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease
James B. Koprich et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
Alfredo Ramirez et al.
NATURE GENETICS (2006)
Share Paper
